AIQ, the Global X Artificial Intelligence & Technology ETF, is caught in a striking split: the fund has surged more than 23% in a month and is up 4.4% on the week, yet options positioning has simultaneously swung to its most defensive stance in over a year.
The most arresting data point right now is how heavily put-heavy the options market has become — even as the ETF itself has been one of the better-performing AI-themed products in the market. The put/call ratio hit 2.64 on May 8, the highest reading of the past 52 weeks, before easing slightly to 2.39. That level runs well above the 20-day average of 2.05. For every call contract outstanding, there are more than two puts — a level of hedging that stands out against a backdrop of sharp price gains. The z-score on the PCR is close to 1.0, modest by itself, but the absolute level near the annual peak signals that options participants are running unusually heavy downside protection even while the ETF climbs.
Short interest tells a very different story — and deliberately so. At just 0.22% of the free float, the short base here is almost negligible. That is the nature of a large-cap, liquid ETF with over $9.5 billion in assets. What is more instructive is the pattern within that tiny float percentage: short shares nearly doubled from early April's ~160,000 to a peak of 1.4 million on April 23, as the broader tech selloff drew in tactical shorts. Since then the position has unwound sharply, falling back to around 345,000 shares. Borrow costs remain cheap at just over 1% annually — well off the mid-April highs above 1.9% — and availability is comfortable at 115% of current short interest, meaning there is ample room for new shorts to enter if sentiment turns. The lending market is not under any strain.
The ORTEX short score of 44 is squarely in neutral territory, consistent with this picture. It has hovered in the low-to-mid 40s for two weeks, drifting neither toward a squeeze setup nor toward an aggressive bearish build. No single directional signal is flashing from the borrow side.
Where the tension lives is squarely in the options data and the price action. The fund is up nearly 24% in a single month — a fast, sharp recovery from the tariff-driven selloff that hit AI-heavy names hard in late March and early April. That kind of move in a diversified tech ETF draws hedgers quickly. The PCR trend tells the story clearly: below 1.5 through most of April's early bounce, it then raced above 2.0 as the rally gathered pace in late April and has stayed elevated since. Options buyers are paying up for puts even at these higher price levels, treating the gains as something to insure rather than extend.
Dividend data is stale from 2022 and no earnings date applies to this structure, so those angles add nothing this week. What matters is whether the divergence between the price trend and the hedging posture narrows — either the PCR cools as conviction in the rally builds, or the price action softens to validate the caution. The May 8 PCR print at the 52-week high is the level to watch.
See the live data behind this article on ORTEX.
Open AIQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
